Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma

被引:86
作者
Shirato, H
Sakamoto, T
Sawamura, Y
Kagei, K
Isu, T
Kato, T
Fukuda, S
Suzuki, K
Soma, S
Inuyama, Y
Miyasaka, K
机构
[1] Hokkaido Univ, Sch Med, Dept Radiol, Kita Ku, Sapporo, Hokkaido 060, Japan
[2] Hokkaido Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 060, Japan
[3] Hokkaido Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido 060, Japan
[4] Obihiro Kohsei Hosp, Dept Radiol, Obihiro, Hokkaido, Japan
[5] Obihiro Kohsei Hosp, Dept Otolaryngol, Obihiro, Hokkaido, Japan
[6] Kushiro Rohsai Hosp, Dept Neurosurg, Kushiro, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1999年 / 44卷 / 03期
关键词
stereotactic radiotherapy; dose fractionation; hearing preservation; observation; vestibular schwannoma;
D O I
10.1016/S0360-3016(99)00079-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the use of an observation policy with that of stereotactic radiotherapy (SRT) for treatment of vestibular schwannoma, Methods and Materials: The study group consisted of 27 patients who underwent observation as an initial treatment (observation group) and 50 who received SRT (SRT group). The mean follow-up period was 35 months and 31 months, respectively. Stereotactic radiotherapy consisted of small-field fractionated radiotherapy (36-44 Gy in 20-22 fractions over 6 weeks) with or without a subsequent 4-Gy single irradiation boost, Results: Actuarial tumor control rate of the SRT group was significantly better than that of the observation group (p < 0.0001). The mean growth was 3.87 mm/year in the observation group and -0.75 mm/year in the SRT group (p < 0.0001). Eleven patients (41%) in the observation group and 1 (2%) in the SRT group received salvage therapy (p < 0.001). There was no difference in the actuarial Gardner and Robertson's class preservation curves for 5 years after the initial presentation. Conclusion: Stereotactic radiotherapy using a fractionated schedule provides a better tumor control rate and a similar rate of deterioration for hearing levels compared to an observation policy. Initial SRT may be a reasonable alternative to a wait-and-see policy. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:545 / 550
页数:6
相关论文
共 29 条
[11]   A new mold material for customized patient positioning in radiotherapy [J].
Kitahara, T ;
Shirato, H ;
Nishioka, T ;
Kagei, K ;
Yamaguchi, M ;
Furuya, T ;
Watanabe, Y ;
Takekawa, N ;
Miyasaka, K .
RADIOTHERAPY AND ONCOLOGY, 1998, 47 (01) :77-79
[12]  
Kondziolka D, 1993, STEREOTACTIC RADIOSU, P175
[13]   FRACTIONATED RADIATION-THERAPY IN THE TREATMENT OF STAGE-III AND STAGE-IV CEREBELLOPONTINE ANGLE NEURINOMAS - PRELIMINARY-RESULTS IN 20 CASES [J].
MAIRE, JP ;
FLOQUET, A ;
DARROUZET, V ;
GUERIN, J ;
BEBEAR, JP ;
CAUDRY, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (01) :147-152
[14]  
Martin C, 1995, Rev Laryngol Otol Rhinol (Bord), V116, P119
[15]   Preliminary results of linear accelerator radiosurgery for acoustic schwannomas [J].
Mendenhall, WM ;
Friedman, WA ;
Buatti, JM ;
Bova, FJ .
JOURNAL OF NEUROSURGERY, 1996, 85 (06) :1013-1019
[16]  
MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P179
[17]   PRESERVATION OF HEARING AND FACIAL-NERVE FUNCTION IN RESECTION OF ACOUSTIC NEUROMA [J].
NADOL, JB ;
CHIONG, CM ;
OJEMANN, RG ;
MCKENNA, MJ ;
MARTUZA, RL ;
MONTGOMERY, WW ;
LEVINE, RA ;
RONNER, SF ;
GLYNN, RJ .
LARYNGOSCOPE, 1992, 102 (10) :1153-1158
[18]  
Sakamoto T, 1998, RADIOTHER ONCOL, V49, P185, DOI 10.1016/S0167-8140(98)00090-5
[19]   Management of 1000 vestibular schwannomas (acoustic neuromas): The facial nerve - Preservation and restitution of function [J].
Samii, M ;
Matthies, C .
NEUROSURGERY, 1997, 40 (04) :684-694
[20]   Management of 1000 vestibular schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complications and how to avoid them [J].
Samii, M ;
Matthies, C .
NEUROSURGERY, 1997, 40 (01) :11-21